Fleur Wood

Fleur has over 25 years of experience in capital markets initially gained within corporate broking teams at investment banks such as UBS, Hoare Govett and Lehman Brothers and since then she has advised clients on all aspects of Investor Relations, corporate strategy and M&A serving as Head of Investor Relations within listed companies in the life sciences and healthcare sector including Vectura Group plc, Shield Therapeutics plc and Open Orphan (hVIVO) plc. She has particular experience working with companies undergoing change and growth.